Efficacy and safety of switching to iGlarLixi from premixed insulin therapy in patients with type 2 diabetes: A real‐world experience

20260 citationsJournal Articlehybrid Open Access

Authors

Chun‐Jui Huang · National Yang Ming Chiao Tung University

S N Yang · Taipei Veterans General Hospital

Cheng‐Pin Cheng · Taipei Veterans General Hospital

Chun‐Hsing Lin · Taipei Veterans General Hospital

Y. S. Lee · Taipei Veterans General Hospital

Harn‐Shen Chen · National Yang Ming Chiao Tung University

Abstract

Switching from premixed insulin to iGlarLixi is a safe and effective strategy to simplify therapy and improve glycaemic management. Insulin resistance may influence response.

Topics & Keywords

Diabetes Management and Research Diabetes Treatment and Management Diabetes and associated disorders

UN Sustainable Development Goals

Zero hunger

Publication Details

Published in: Diabetic Medicine

DOI: 10.1111/dme.70275

Field-Weighted Citation Impact: 0.00